Literature DB >> 17913523

Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1.

Leopoldo Laricchia-Robbio1, Giuseppina Nucifora.   

Abstract

EVI1 was first identified as a preferential integration site of ecotropic retroviruses in the MDS1/EVI1 genomic locus leading to myeloid tumors in susceptible mice. Later studies showed that retroviral integration in the MDS1/EVI1 locus results in the emergence of a non-malignant dominant hematopoietic stem cell clone in non-susceptible mice strains, in non-human primates, and in patients, suggesting that a gene encoded by the locus could affect the self-renewal potential of a cell. The locus encodes two genes. One of them, EVI1, has long been associated with myeloid leukemia. To understand whether EVI1 has a role in self-renewal control, we forcibly expressed EVI1 in the bone marrow progenitors of two mice strains that differ in their proliferation and self-renewal potential. By comparing the response of the hematopoietic cells to EVI1, we conclude that EVI1 has a role in prolonging the self-renewal potential of the cells and that this ability of EVI1 is limited and modulated by inherent characteristics of the cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913523      PMCID: PMC2323624          DOI: 10.1016/j.bcmd.2007.07.012

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  16 in total

1.  Genetic analysis of hemopoietic cell cycling in mice suggests its involvement in organismal life span.

Authors:  G De Haan; G Van Zant
Journal:  FASEB J       Date:  1999-04       Impact factor: 5.191

2.  HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.

Authors:  Jennifer Antonchuk; Guy Sauvageau; R Keith Humphries
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

3.  The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development.

Authors:  P R Hoyt; C Bartholomew; A J Davis; K Yutzey; L W Gamer; S S Potter; J N Ihle; M L Mucenski
Journal:  Mech Dev       Date:  1997-07       Impact factor: 1.882

4.  Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

Authors:  Boris Calmels; Cole Ferguson; Mikko O Laukkanen; Rima Adler; Marion Faulhaber; Hyeoung-Joon Kim; Stephanie Sellers; Peiman Hematti; Manfred Schmidt; Christof von Kalle; Keiko Akagi; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

5.  Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity.

Authors:  G de Haan; W Nijhof; G Van Zant
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

6.  Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.

Authors:  Leopoldo Laricchia-Robbio; Raffaella Fazzina; Donglan Li; Ciro R Rinaldi; Kisaly K Sinha; Soumen Chakraborty; Giuseppina Nucifora
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

7.  Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers.

Authors:  G de Haan; S J Szilvassy; T E Meyerrose; B Dontje; B Grimes; G Van Zant
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

8.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

9.  EVI1 induces myelodysplastic syndrome in mice.

Authors:  Silvia Buonamici; Donglan Li; Yiqing Chi; Rui Zhao; Xuerong Wang; Larry Brace; Hongyu Ni; Yogen Saunthararajah; Giuseppina Nucifora
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development.

Authors:  A S Perkins; J A Mercer; N A Jenkins; N G Copeland
Journal:  Development       Date:  1991-02       Impact factor: 6.868

View more
  16 in total

Review 1.  Gene therapy of chronic granulomatous disease: the engraftment dilemma.

Authors:  Manuel Grez; Janine Reichenbach; Joachim Schwäble; Reinhard Seger; Mary C Dinauer; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

2.  Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome.

Authors:  Jerome Dickstein; Vitalyi Senyuk; Kavitha Premanand; Leopoldo Laricchia-Robbio; Peng Xu; Francesca Cattaneo; Raffaella Fazzina; Giuseppina Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

3.  Expression Pattern and Prognostic Significance of EVI1 Gene in Adult Acute Myeloid Leukemia Patients with Normal Karyotype.

Authors:  Irena Marjanovic; Teodora Karan-Djurasevic; Tatjana Kostic; Marijana Virijevic; Nada Suvajdzic-Vukovic; Sonja Pavlovic; Natasa Tosic
Journal:  Indian J Hematol Blood Transfus       Date:  2019-11-04       Impact factor: 0.900

Review 4.  Unraveling the molecular pathophysiology of myelodysplastic syndromes.

Authors:  Rafael Bejar; Ross Levine; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

5.  High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.

Authors:  Phoenix A Ho; Todd A Alonzo; Robert B Gerbing; Jessica A Pollard; Betsy Hirsch; Susana C Raimondi; Todd Cooper; Alan S Gamis; Soheil Meshinchi
Journal:  Br J Haematol       Date:  2013-07-04       Impact factor: 6.998

6.  EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.

Authors:  Eric M J Bindels; Marije Havermans; Sanne Lugthart; Claudia Erpelinck; Elizabeth Wocjtowicz; Andrei V Krivtsov; Elwin Rombouts; Scott A Armstrong; Erdogan Taskesen; Jurgen R Haanstra; H Berna Beverloo; Hartmut Döhner; Wendy A Hudson; John H Kersey; Ruud Delwel; Ashish R Kumar
Journal:  Blood       Date:  2012-05-02       Impact factor: 22.113

7.  Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.

Authors:  Heesun J Rogers; James W Vardiman; John Anastasi; Gordana Raca; Natasha M Savage; Athena M Cherry; Daniel Arber; Erika Moore; Jennifer J D Morrissette; Adam Bagg; Yen-Chun Liu; Susan Mathew; Attilio Orazi; Pei Lin; Sa A Wang; Carlos E Bueso-Ramos; Kathryn Foucar; Robert P Hasserjian; Ramon V Tiu; Matthew Karafa; Eric D Hsi
Journal:  Haematologica       Date:  2014-01-24       Impact factor: 9.941

8.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.

Authors:  Stefan Stein; Marion G Ott; Stephan Schultze-Strasser; Anna Jauch; Barbara Burwinkel; Andrea Kinner; Manfred Schmidt; Alwin Krämer; Joachim Schwäble; Hanno Glimm; Ulrike Koehl; Carolin Preiss; Claudia Ball; Hans Martin; Gudrun Göhring; Kerstin Schwarzwaelder; Wolf-Karsten Hofmann; Kadin Karakaya; Sandrine Tchatchou; Rongxi Yang; Petra Reinecke; Klaus Kühlcke; Brigitte Schlegelberger; Adrian J Thrasher; Dieter Hoelzer; Reinhard Seger; Christof von Kalle; Manuel Grez
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

9.  Pharmacological Inhibition of p38 MAPK Rejuvenates Bone Marrow Derived-Mesenchymal Stromal Cells and Boosts their Hematopoietic Stem Cell-Supportive Ability.

Authors:  Pallavi Budgude; Vaijayanti Kale; Anuradha Vaidya
Journal:  Stem Cell Rev Rep       Date:  2021-08-22       Impact factor: 5.739

10.  EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages.

Authors:  Katarina Steinleitner; Paulina Rampetsreiter; Rene Köffel; Gajalakshmi Ramanathan; Christine Mannhalter; Herbert Strobl; Rotraud Wieser
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.